TWO SIGMA ADVISERS, LP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 115 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$74,000
+39.6%
16,000
+6.0%
0.00%
Q4 2018$53,000
-91.8%
15,100
-78.5%
0.00%
-100.0%
Q4 2016$646,000
+18.3%
70,200
+51.6%
0.00%0.0%
Q3 2016$546,000
-53.5%
46,300
-49.0%
0.00%
-66.7%
Q2 2016$1,174,000
-28.3%
90,700
-11.4%
0.01%
-33.3%
Q1 2016$1,637,000
+6.5%
102,400
+90.7%
0.01%0.0%
Q4 2015$1,537,000
+618.2%
53,700
+656.3%
0.01%
+800.0%
Q3 2015$214,000
-90.9%
7,100
-89.1%
0.00%
-94.4%
Q2 2015$2,346,000
+140.4%
65,300
+177.3%
0.02%
+100.0%
Q1 2014$976,00023,5490.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders